| budesonide/formoterol / Generic mfg. |
ChiCTR1800017584: Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease |
|
|
| Completed | N/A | 180 | | Budesonide/formoterol (Symbicort; 160 μg/4.5 μg; 1 suction/time, 2 times/day); treatment of tiotropium bromide (Spiriva; 1.8 μg inhaled once a day before sleeping). ;Bbudesonide/formoterol (Symbicort; 160 μg/4.5 μg; 1 suction/time, 2 times/day). | The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University, None | Moderate to severe chronic obstructive pulmonary disease | | | | |
ChiCTR1800019852: The efficacy of budesonide/formoterol in cough variant asthma: A Multi-center Randomized, Controlled Clinical Trial |
|
|
| Recruiting | N/A | 500 | | budesonide/formoterol (Symbicort) 160/4.5ug 2 inhalation bid* 3 months ;budesonide/formoterol (Symbicort) 160/4.5ug 1 inhalation bid* 3 months | Second Affiliated Hospital, Zhejiang University School of Medicine; Second Affiliated Hospital, Zhejiang University School of Medicine, support by AstraZeneca | cough variant asthma | | | | |
ChiCTR2000030452: Multicenter prospective randomized controlled trial for Dong-Tian Chang-Chun Ointment in the treatment of stable COPD patients |
|
|
| Not yet recruiting | N/A | 96 | | Dongtian Changchun Ointment+Symbicort Turbuhaler ;Symbicort Turbuhaler | Zhongshan Hospital Affiliated Fudan University; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Zhongshan Hospital Affiliated Fudan University, Key projects for prevention and control of chronic noncommunicable diseases in the 13th five-year plan of the ministry of science and technology | Chronic obstructive pulmonary disease | | | | |
ChiCTR2000036980: Clinical study on the effect of Sansang Shenqi Decoction on airway function in patients with chronic obstructive pulmonary disease at stable period |
|
|
| Recruiting | N/A | 200 | | Sansang Shenqi Decoction+Symbicort Turbuhaler ;Symbicort Turbuhaler | LongHua Hospital Shanghai University of Traditional Chinese Medicine; Level of the institution：, Shanghai Shenkang Hospital Development Center | chronic obstructive pulmonary disease | | | | |
NCT06105671: U-LABA/ICS Effects on Exercise Performance, Formoterol |
|
|
| Not yet recruiting | N/A | 24 | Europe | Symbicort, Formoterol, Placebo, Mannitol | Morten Hostrup, PhD | Exercise Performance | 12/25 | 12/25 | | |
NCT00576069: Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma |
|
|
| Recruiting | N/A | 60 | US | budesonide/formoterol, symbicort 80/4.5, symbicort 160/4.5, budesonide 80 or 160ug/formoterol 4.5ug, 2 inhalations bid, spiriva handihaler or respihaler, fluticasone/salmeterol, advair 100/50, advair 250/50, mometasone/formoterol, Dulera, Prednisone, medrol | Gelb, Arthur F., M.D. | Asthma | 06/27 | 06/27 | | |
